TY - JOUR AB - Following the publication of this paper, it was drawn to the Editors’ attention by a concerned reader that the Transwell cell migration assay data shown in Fig. 2C were strikingly similar to data appearing in different form in other articles by different authors. Owing to the fact that the contentious data in the above article had already been published elsewhere, or were already under consideration for publication, prior to its submission to Experimental and Therapeutic Medicine, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive any reply. The Editor apologizes to the readership for any inconvenience caused. [the original article was published in Experimental and Therapeutic Medicine 14: 1547‑1553, 2017; DOI: 10.3892/etm.2017.4648] AD - Department of Orthopedics, Third Xiangya Hospital of Central South University, Changsha, Hunan 410013, P.R. China AU - Wang,Zili AU - Zheng,Chenhuang AU - Jiang,Kunqi AU - He,Jinshen AU - Cao,Xu AU - Wu,Song DA - 2021/12/01 DO - 10.3892/etm.2021.10845 IS - 6 JO - Exp Ther Med KW - osteosarcoma microRNA proliferation invasion insulin-like growth factor 1 receptor PY - 2021 SN - 1792-0981 1792-1015 SP - 1409 ST - [Retracted] MicroRNA‑503 suppresses cell proliferation and invasion in osteosarcoma via targeting insulin‑like growth factor 1 receptor T2 - Experimental and Therapeutic Medicine TI - [Retracted] MicroRNA‑503 suppresses cell proliferation and invasion in osteosarcoma via targeting insulin‑like growth factor 1 receptor UR - https://doi.org/10.3892/etm.2021.10845 VL - 22 ER -